Despite the marked success of molecular targeted therapy in lung cancer in this era of
personalized medicine, its efficacy has been limited by the presence of resistance …

Lung cancer is the leading cause of cancer-related death worldwide. Although natural killer
(NK) cells are garnering interest as a potential anticancer therapy because they selectively …

Purpose One of the key immune cells involved in the pathogenesis of lung cancer is natural
killer (NK) cells and these cells are novel targets for therapeutic applications in lung cancer …

In recent years, progress has been made in the characterization of natural killer (NK) cells in
lung malignancies, and we have now gained a better understanding of the frequency …

Background Natural killer (NK) cells can be used as an adoptive immunotherapy to treat
cancer patients. Purpose In this study, we evaluated the efficacy of highly activated NK …

Lung cancer is the leading cause of cancer-related deaths worldwide. There are two main
subtypes: small cell lung cancer (SCLC), and non-small cell lung cancer (NSCLC). NSCLC …

Introduction: Lung cancer is a devastating disease with poor overall survival. Despite
significant advances in the treatment of lung cancers using radiochemotherapy, targeted …

The lungs, a special site that is frequently challenged by tumors, pathogens and other
environmental insults, are populated by large numbers of innate immune cells. Among …

Natural killer (NK) cells are immune cells which are able to kill tumor and virus-infected cells
and play an important role in both innate immunity and acquired immunity. Tumor …

As our understanding of the molecular mechanisms governing natural killer (NK) cell activity
increases, their potential in cancer immunotherapy is growing increasingly prominent. This …